Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetics and molecular biology: macrophage ACAT depletion

× No keyword cloud information.

26 in total

1. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.

Authors: S Perrey; C Legendre; A Matsuura; C Guffroy; J Binet; S Ohbayashi; T Tanaka; J C Ortuno; T Matsukura; T Laugel; P Padovani; F Bellamy; A D Edgar
Journal: Atherosclerosis Date: 2001-04 Impact factor: 5.162

Review 2. Mammalian acyl-CoA:cholesterol acyltransferases.

Authors: K F Buhman; M Accad; R V Farese
Journal: Biochim Biophys Acta Date: 2000-12-15

3. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

Authors: M Accad; S J Smith; D L Newland; D A Sanan; L E King; M F Linton; S Fazio; R V Farese
Journal: J Clin Invest Date: 2000-03 Impact factor: 14.808

4. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors: J Kusunoki; D K Hansoty; K Aragane; J T Fallon; J J Badimon; E A Fisher
Journal: Circulation Date: 2001-05-29 Impact factor: 29.690

5. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.

Authors: D Riddell; C P Bright; B J Burton; R C Bush; N V Harris; D Hele; U M Moore; K Naik; D P Parrott; C Smith; R J Williams
Journal: Biochem Pharmacol Date: 1996-10-25 Impact factor: 5.858

6. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.

Authors: Y Sugiyama; E Ishikawa; H Odaka; N Miki; H Tawada; H Ikeda
Journal: Atherosclerosis Date: 1995-02 Impact factor: 5.162

7. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol.

Authors: G J Warner; G Stoudt; M Bamberger; W J Johnson; G H Rothblat
Journal: J Biol Chem Date: 1995-03-17 Impact factor: 5.157

8. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.

Authors: M Matsuo; F Ito; A Konto; M Aketa; M Tomoi; K Shimomura
Journal: Biochim Biophys Acta Date: 1995-12-07

9. Cholesterol absorption and hepatic acyl-coenzyme A:cholesterol acyltransferase activity play major roles in lipemic response to dietary cholesterol and fat in laboratory opossums.

Authors: Rampratap S Kushwaha; Jane F Vandeberg; Roxanne Rodriguez; John L Vandeberg
Journal: Metabolism Date: 2004-06 Impact factor: 8.694

10. An inhibitor of acylCoA: cholesterol acyltransferase increases expression of ATP-binding cassette transporter A1 and thereby enhances the ApoA-I-mediated release of cholesterol from macrophages.

Authors: Kanami Sugimoto; Maki Tsujita; Cheng-Ai Wu; Kazuo Suzuki; Shinji Yokoyama
Journal: Biochim Biophys Acta Date: 2004-02-27

2 in total

1. Development of a Synthetic 3-ketosteroid Δ¹-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells.

Authors: Brandon M D'Arcy; Mark R Swingle; Lindsay Schambeau; Lewis Pannell; Aishwarya Prakash; Richard E Honkanen
Journal: Sci Rep Date: 2019-04-12 Impact factor: 4.379

2. De novo labeling and trafficking of individual lipid species in live cells.

Authors: Jun Zhang; Jia Nie; Haoran Sun; Jie Li; John-Paul Andersen; Yuguang Shi
Journal: Mol Metab Date: 2022-05-02 Impact factor: 8.568

2 in total